Another [ 35 ] found a slower mean rate of fibrosis progression over approximately 15 years in patients undertaking cART at follow-up, although the difference did not reach statistical significance.
← all excerpts
Antiretroviral therapy and liver disease progression in HIV and hepatitis C co-infected patients: a systematic review and meta-analysis.
1
—
—